Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Interactive Intention-Driven Upper-Limb Training Robotic System

23. februar 2017 oppdatert av: Raymond KY Tong, The Hong Kong Polytechnic University

Trial: Interactive Intention-Driven Upper-Limb Training Robotic System

The goal of this study is to determine robotic hand system is more effective than conventional physical and occupational therapy at promoting functional recovery of the affected arm in subjects after stroke.

Studieoversikt

Detaljert beskrivelse

This study will investigate the recovery in hand and upper limb functions when the physical training is assisted by an exoskeleton robotic hand system.

Subjects with a pure unilateral motor paresis after a stroke (ischemic or hemorrhagic). All subjects should have sufficient cognition to follow simple instructions as well as understand the content and purpose of the experiment, and also should be able to sit up for 1 hour.

During the training, you will be asked to do the hand open and hand grasp by Electromyography-driven robotic control strategy.

There will be evaluations on the upper limb motor functions before and after the 20-session of training and follow up session by clinical assessments on functional recovery.

Studietype

Intervensjonell

Registrering (Forventet)

70

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Hong Kong, Hong Kong
        • The Hong Kong Polytechnic University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 100 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Subjects with a pure unilateral motor paresis after a stroke (ischemic or hemorrhagic). All subjects should have sufficient cognition to follow simple instructions as well as understand the content and purpose of the experiment, and also should be able to sit up for 1 hour.

Exclusion Criteria:

  • Excessive spasticity of the affected arm
  • Participation in any therapeutic treatment ("outside therapy") performed with the paralyzed arm during the planned study - including baseline and follow up.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Hand Robotic Training
Training for 20 sessions for one hour, 3-5 times per week.
Eksperimentell: Hand and Arm Robotic Training
Training for 20 sessions for one hour, 3-5 times per week.
Aktiv komparator: Konvensjonell terapi
Training for 20 sessions for one hour, 3-5 times per week.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Fugl-Meyer Assessment
Tidsramme: Change from baseline Fugl-Meyer Assessment at the end of intervention, at three months and at six months

Evaluate the change from baseline assessment at the end of intervention and monitor the continuous change at three months and six months.

Baseline assessment will be conducted at within one week prior to intervention. Participants will be followed for the duration of hospital stay, an expected average of 5 weeks for the 20-session intervention. The assessment at the end of intervention will be conducted within one week after the intervention. The other two assessments will be conducted at three months and six months after the last session of the intervention.

Change from baseline Fugl-Meyer Assessment at the end of intervention, at three months and at six months
Action Research Arm Test
Tidsramme: Change from baseline Action Research Arm Test at the end of intervention, at three months and at six months

Evaluate the change from baseline test at the end of intervention and monitor the continuous change at three months and six months.

Baseline test will be conducted at within one week prior to intervention. Participants will be followed for the duration of hospital stay, an expected average of 5 weeks for the 20-session intervention. The assessment at the end of intervention will be conducted within one week after the intervention. The other two assessments will be conducted at three months and six months after the last session of the intervention.

Change from baseline Action Research Arm Test at the end of intervention, at three months and at six months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Wolf Motor Function Test
Tidsramme: Change from baseline Wolf Motor Function Test at the end of intervention, at three months and at six months

Evaluate the change from baseline test at the end of intervention and monitor the continuous change at three months and six months.

Baseline test will be conducted at within one week prior to intervention. Participants will be followed for the duration of hospital stay, an expected average of 5 weeks for the 20-session intervention. The assessment at the end of intervention will be conducted within one week after the intervention. The other two assessments will be conducted at three months and six months after the last session of the intervention.

Change from baseline Wolf Motor Function Test at the end of intervention, at three months and at six months
modified Ashworth Scale
Tidsramme: Change from baseline modified Ashworth Scale at the end of intervention, at three months and at six months

Evaluate the change from baseline test at the end of intervention and monitor the continuous change at three months and six months.

Baseline test will be conducted at within one week prior to intervention. Participants will be followed for the duration of hospital stay, an expected average of 5 weeks for the 20-session intervention. The assessment at the end of intervention will be conducted within one week after the intervention. The other two assessments will be conducted at three months and six months after the last session of the intervention.

Change from baseline modified Ashworth Scale at the end of intervention, at three months and at six months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Raymond KY Tong, PhD, The Hong Kong Polytechnic University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. januar 2014

Primær fullføring (Faktiske)

31. desember 2015

Studiet fullført (Faktiske)

31. desember 2016

Datoer for studieregistrering

Først innsendt

27. februar 2014

Først innsendt som oppfylte QC-kriteriene

3. mars 2014

Først lagt ut (Anslag)

4. mars 2014

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

24. februar 2017

Siste oppdatering sendt inn som oppfylte QC-kriteriene

23. februar 2017

Sist bekreftet

1. februar 2017

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere